1-O-(3-HYDROXY-4-METHOXYPHENETHYL)-4-O-(PARA-HYDROXY-COUMAROYL)-3-O-ALPHA-L-RHAMNOPYRANOSYL-BETA-D-GLUCOPYRANOSIDE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | I2GN21BDBOS |
|---|---|
| InChI | InChI=1S/C30H38O14/c1-15-23(35)24(36)25(37)30(41-15)44-28-26(38)29(40-12-11-17-5-9-20(39-2)19(33)13-17)42-21(14-31)27(28)43-22(34)10-6-16-3-7-18(32)8-4-16/h3-10,13,15,21,23-33,35-38H,11-12,14H2,1-2H3/b10-6+/t15-,21-,23-,24+,25+,26-,27-,28-,29-,30-/m0/s1 |
| InChIKey | PVTLBECPUJCOKK-SCTFZZTKSA-N |
| Mol Weight | 622.6 g/mol |
| Molecular Formula | C30H38O14 |
| Exact Mass | 622.226156 g/mol |
| Enantiomer InChIKey | PVTLBECPUJCOKK-KKTXZHOBSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
LIPEDOSIDE-A-I;[2-(3,4-DIHYDROXYPHENYL)-ETHYL]-(3-O-ALPHA-L-RHAMNOPYRANOSYL)-(4-O-PARA-COUMAROYL)-BETA-D-GLUCOPYRANOSIDE
PHTEIROSPERMOSIDE;3,4-DIHYDROXY-BETA-PHENETHYL-O-ALPHA-L-RHAMNOPYRANOSYL-(1->3)-4-O-ISOFERULOYL-BETA-D-GLUCOPYRANOSIDE
EUKOVOSIDE
ACTEOSIDE;FRACTION-I
1'-O-BETA-(3,4-DIHYDROXYPHENYL)-ETHYL-4'-O-CAFFEOYL-ALPHA-L-FUCOPYRANOSYL-(1->3')-D-GLUCOPYRANOSIDE
ACTEOSIDE;3,4-DIHYDROXYPHENETHYL-O-ALPHA-L-RHAMNOPYRANOSYL-(1->3)-4-O-CAFFEOYL-BETA-D-GLUCOPYRANOSIDE
ACTEOSIDE;3,4-DIHYDROXY-BETA-PHENYLETHOXY-O-ALPHA-L-RHAMNOPYRANOSYL-(1->3)-4-O-CAFFEOYL-BETA-D-GLUCOPYRANOSIDE
2-(4-Hydroxy-3-methoxyphenyl)ethyl 3-O-(6-deoxyhexopyranosyl)-4-O-[(2E)-3-(4-hydroxy-3-methoxyphenyl)-2-propenoyl]hexopyranoside
SYRINGALIDE-A-3'-ALPHA-L-RHAMNOPYRANOSIDE;FRACTION-III
| Title | Journal or Book | Year |
|---|---|---|
| Phenylethanoid and lignan-iridoid complex glycosides from roots of Buddleja davidii | Phytochemistry | 1993 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.